Gilmour Duncan 4
4 · INTEST CORP · Filed Mar 5, 2026
Insider Transaction Report
Form 4
INTEST CORPINTT
Gilmour Duncan
CFO, Treasurer & Secretary
Transactions
- Disposition to Issuer
Common Stock
[F1]2026-03-04−4,670→ 56,434 total
Holdings
- 200(indirect: By Spouse)
Common stock
- 1,992
Employee Stock Option (right to buy)
[F2]Exercise: $7.74Exp: 2035-03-16→ Common Stock (1,992 underlying) - 18,077
Employee Stock Option (right to buy)
[F3]Exercise: $7.74Exp: 2035-03-16→ Common Stock (18,077 underlying) - 12,724
Employee Stock Option (right to buy)
[F4]Exercise: $11.33Exp: 2034-03-05→ Common Stock (12,724 underlying) - 8,044
Employee Stock Option (right to buy)
[F5]Exercise: $16.06Exp: 2033-03-07→ Common Stock (8,044 underlying) - 12,848
Employee Stock Option (right to buy)
[F6]Exercise: $9.76Exp: 2032-03-08→ Common Stock (12,848 underlying) - 8,104
Employee Stock Option (right to buy)
[F7]Exercise: $16.80Exp: 2031-06-13→ Common Stock (8,104 underlying)
Footnotes (7)
- [F1]Shares forfeited under the terms of Mr. Gilmour's performance-based restricted stock award granted on March 8, 2023.
- [F2]This option vests in four equal annual installments commencing on March 17, 2026.
- [F3]This option vests in four equal annual installments commencing on March 17, 2026.
- [F4]This option vests in four equal annual installments commencing on March 6, 2025.
- [F5]This option vests in four equal annual installments commencing on March 8, 2024.
- [F6]This option vests in four equal annual installments commencing on March 9, 2023.
- [F7]This option is fully vested as of the date of this report.
Signature
/s/ Duncan Gilmour|2026-03-05